<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Although patients with <z:hpo ids='HP_0001953'>diabetic ketoacidosis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DKA</z:e>) are expected to have total body <z:chebi fb="120" ids="26216">potassium</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath>, measured levels may be <z:mpath ids='MPATH_458'>normal</z:mpath> or elevated due to extracellular shifts of <z:chebi fb="120" ids="26216">potassium</z:chebi> secondary to <z:hpo ids='HP_0001941'>acidosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Because insulin therapy decreases serum <z:chebi fb="120" ids="26216">potassium</z:chebi> levels, which creates potential to precipitate a fatal <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> in a patient with <z:hpo ids='HP_0002900'>hypokalemia</z:hpo>, the American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association (<z:chebi fb="36" ids="39048">ADA</z:chebi>) recommends obtaining a serum <z:chebi fb="120" ids="26216">potassium</z:chebi> level before giving insulin </plain></SENT>
<SENT sid="2" pm="."><plain>Although the <z:chebi fb="36" ids="39048">ADA</z:chebi> guidelines are clear, the evidence on which they are based is largely anecdotal </plain></SENT>
<SENT sid="3" pm="."><plain>The purpose of this study was to estimate the prevalence of <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DKA</z:e> before initiation of fluid resuscitation and insulin therapy </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: This is a prospective cross-sectional descriptive study of patients with a capillary blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level of 250 mg/dL or higher (at risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DKA</z:e>) seen in an urban county emergency department over a 1-year period </plain></SENT>
<SENT sid="5" pm="."><plain>Those who consented provided basic demographic information and had a venous blood gas and chemistry panel drawn </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001953'>Diabetic ketoacidosis</z:hpo> and <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> were defined using <z:chebi fb="36" ids="39048">ADA</z:chebi> recommendations </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The mean age in our sample was 40.2 years, and 81% of patients were Hispanic </plain></SENT>
<SENT sid="8" pm="."><plain>Of 503 analyzable patients with <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, 54 (10.7%) met <z:hpo ids='HP_0000001'>all</z:hpo> criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DKA</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DKA</z:e>, 3 (5.6%) of 54 (95% confidence interval, 1.2%-15.4%) had <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Two of these patients had values of 3.0 mmol/L, and 1 had a value of 2.8 mmol/L </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0002900'>Hypokalemia</z:hpo> was observed in 5.6% of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DKA</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>These findings support the <z:chebi fb="36" ids="39048">ADA</z:chebi> recommendation to obtain a serum <z:chebi fb="120" ids="26216">potassium</z:chebi> before initiating intravenous insulin therapy in a patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DKA</z:e> </plain></SENT>
</text></document>